Immunology
News
FDA pulls U.S. authorization for Eli Lilly’s COVID drug bebtelovimab
The drug is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
News
Buzzy Lancet long COVID paper under investigation for ‘data errors’
A reader found inconsistencies between the data in the article and a later paper describing the same cohort of patients after a year of follow-up...
News
Covid vax prevents death in children regardless of variant
But the vaccine’s effectiveness decreased over time.
News
More vaccinated people dying of COVID as fewer get booster shots
But the case for the effectiveness of vaccines and boosters versus skipping the shots remains strong.
Latest News
Experts explain the ‘perfect storm’ of rampant RSV and flu
“Decreased exposure to endemic viruses created an immunity gap – a group of susceptible individuals who avoided infection and therefore lack...
Latest News
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
An ongoing phase 2 trail shows the vaccine offered the strongest protection in people older than 55 years.
News
Evusheld PrEP may protect immunocompromised patients from severe COVID-19
Evusheld preexposure prophylaxis shows promise in protecting certain immunocompromised patients from severe COVID-19, Cleveland Clinic researchers...
Reports From the Field
Improving Inpatient COVID-19 Vaccination Rates Among Adult Patients at a Tertiary Academic Medical Center
Perspectives
Author Q&A: Intravenous Immunoglobulin for Treatment of COVID-19 in Select Patients
Latest News
Evusheld for COVID-19: Lifesaving and free, but still few takers
“HHS hasn’t made a major educational effort to promote it.”